Skip to main content
Download PDF

Is severe maternal morbidity a risk factor for postpartum hospitalization with mental health or substance use disorder diagnoses? Findings from a retrospective cohort study in Maryland: 2016–2019

Maternal Health, Neonatology and Perinatology volume 11, Article number: 1 (2025) Cite this article

Abstract

Background

Perinatal mental health conditions and substance use are leading causes, often co-occurring, of pregnancy-related and pregnancy-associated deaths in the United States. This study compares odds of hospitalization with a mental health condition or substance use disorder or both during the first year postpartum between patients with and without severe maternal morbidity (SMM) during delivery hospitalization.

Methods

Data are from the Maryland’s State Inpatient Database and include patients with a delivery hospitalization during 2016–2018 (n = 197,749). We compare rate of hospitalization with a mental health condition or substance use disorder or both at 42 days and 43 days to 1 year postpartum by occurrence of SMM during the delivery hospitalization. We use multivariable logistic regression to derive the odds of hospitalization with each outcome for patients by SMM status, adjusted for patient sociodemographic characteristics, presence of mental health condition or substance use disorder diagnoses during the delivery hospitalization, and delivery outcome. All SMM, mental health conditions, and substance use disorders are identified using ICD-10 diagnosis and procedure codes.

Results

Overall, 5,793 patients (2.9%) who delivered during 2016–2018 experienced hospitalization in the year following delivery. Among these patients, 24.3% (n = 1,410) had a mental health condition diagnosis, 10.6% (n = 619) had a substance use disorder diagnosis, and 9.8% (n = 570) had co-occurring mental health condition and substance use disorder diagnoses. Patients with SMM had 3.7 times the adjusted odds (95% CI 2.7, 5.2) of hospitalization with a mental health condition diagnosis, 2.7 times the odds (95% CI 1.6, 4.4) of a hospitalization with substance use disorder diagnosis, and 3.0 times the odds (95% CI 1.8, 4.8) of hospitalization with co-occurring mental health condition and substance use disorder diagnoses during the first-year postpartum.

Conclusion

Patients who experience SMM during their delivery hospitalization had higher odds of hospitalization with a mental health condition, substance use disorder, and co-occurring mental health condition and substance use disorder in the one-year postpartum period. Treatment and support resources for mental health and substance use providers --including enhanced screening and personal introduction of providers -- should be made available to patients with SMM upon discharge after delivery, and evidence-based interventions to improve mental health and reduce substance use should be prioritized in these patients.

Background

The prevalence of perinatal (i.e. during pregnancy or within one year of giving birth) mental health conditions, including depression, anxiety, bipolar disorder, and suicidality, has doubled in the past two decades in the United States, affecting more than 20% of pregnant and postpartum (i.e. the one year period following childbirth) people annually [1,2,3,4]. Perinatal substance use and substance use disorders have also risen dramatically, with 6.5 cases of opioid use disorder reported per 1,000 delivery hospitalizations in 2016 [5, 6]. In fact, mental health conditions and substance use disorders are leading causes of pregnancy-related and pregnancy-associated death in the United States [7, 8], and have also been associated with adverse maternal (e.g. drug overdose or suicide during the perinatal period), neonatal and infant outcomes (e.g. preterm birth, neonatal abstinence syndrome, growth impairments) [9], and increased delivery hospitalization costs [10, 11]. Notably, presence of a mental health condition diagnosis during the delivery hospitalization has been shown to be associated with an increased likelihood of severe maternal morbidity (SMM) [3, 10, 12], the rate of which also increased by 22.5% between 2008 and 2021 in the US. SMM are unexpected outcomes of labor and delivery that can have long-term consequences on women’s health [13, 14]. SMM are most often identified using a Centers for Disease Control and Prevention (CDC) algorithm for 21 severe morbidity indicators that can occur during a delivery hospitalization and be identified using ICD-10-CM codes.12,13 For example, in 2019, disseminated intravascular coagulation was the most common indicator of SMM, followed by acute kidney failure [15]. Less is known about the relationship between SMM and postpartum mental health, although recent studies indicate an increased risk of such conditions following an SMM event [16, 17]. These findings are consistent with qualitative evidence in which patients describe their SMM events as having long-term negative psychological impacts [18,19,20]. Despite the recognized co-occurrence of mental health conditions and substance use disorders [21, 22], these conditions are not usually examined in tandem among peripartum individuals.

Data from all hospital admissions within one year postpartum in Maryland offer the opportunity of exploring the association between SMM and postpartum mental health and substance use, both separately and as co-occurring morbidities. The objective of this study is to examine rates of hospitalization with a mental health condition, or substance use disorder, or both during the first year postpartum among patients with and without SMM during delivery hospitalization in Maryland over a 4-year period before the start of the COVID-19 pandemic.

Materials and methods

We conducted a retrospective cohort study using 2016–2019 Maryland State Inpatient Database (SID) maintained by the Agency for Healthcare Research and Quality for the Healthcare Cost and Utilization Project (HCUP). The Maryland SID contains all inpatient discharge records from community hospitals in the state and are reported by the State of Maryland’s Health Services Cost Review Commission. We included all delivery hospitalizations among females of reproductive age (15–49 years). Delivery discharge records for 2016–2018 were identified using the International Classification of Diseases 10th Revision, Clinical Modification (ICD-10-CM) diagnosis codes and procedure codes among patients identified as female and of reproductive age (15–49 years). Postpartum hospitalizations for the period of 2016–2019 were identified using a unique patient identifier which is consistent across admissions and facilities over time in the Maryland SID. Exclusion criteria included missing the record linkage ID number, being male or missing sex information, not being of reproductive age, and having no delivery hospitalization during the observation period.

The 3 primary outcomes for the analysis were postpartum hospital admission with a mental health condition, a substance use disorder, and both. Outcome assessment was based on the presence of at least one ICD-10-CM diagnosis code for a mental health condition or substance use disorder among the first five ICD-10-CM diagnosis codes listed for each patient (a full list of ICD-10-CM diagnosis codes used to identify outcomes are included in A1); of note, SID allows up to 30 diagnosis and procedure ICD codes to be listed for each hospital discharge. Within the sample of patients with at least one delivery during 2016–2018, 82.2% of records included at least 5 diagnosis codes, 70.0% had 6 or more diagnosis codes. For deriving the co-occurring disorders outcome, we included individuals with a mental health condition or a substance use disorder diagnosis among the first 5 diagnoses listed who also had a diagnosis code for the other type of disorder listed for the same hospital discharge. Outcomes were identified from the day after discharge from the delivery hospitalization through 365 days following delivery. To examine outcomes one year postpartum, the sample was restricted to patients with deliveries occurring during 2016–2018 to allow for sufficient follow up time in 2019 data.

The main exposure of interest was experience of SMM, defined using CDC’s SMM ICD-10-CM algorithm based on ICD-10-CM diagnoses and procedures noted during the delivery hospitalization [14]. In line with the most recent literature, patients with only blood transfusion ICD-10-CM codes were not deemed as having experienced SMM due to low positive predictive value of SMM using ICD-10-CM codes for this specific indicator [23]. Covariates included patient sociodemographic information: age, race/ethnicity (categorized as non-Hispanic Black, non-Hispanic White, Hispanic, and other/multiple races using HCUP’s standard variables for race and ethnicity), income quartile for the patient’s zip code, delivery hospitalization payer (private, public, self-pay/none), and location of residence (urban or rural). Potential confounders included were the presence of a maternal mental health condition, or a substance use disorder noted during delivery hospitalization, as well as the delivery outcome (stillbirth or live birth).

These characteristics were compared between patients with and without SMM using Pearson chi-square analyses. Rates of hospitalization during the early (within 42 days) and late (43–365 days) postpartum periods were calculated for patients with and without SMM and for each outcome of interest (hospitalization with a mental health condition, a substance use disorder, and co-occurring mental health condition and substance use disorder). Unadjusted and multivariable logistical regression models were fitted to assess the relationship between SMM during delivery hospitalization and postpartum hospitalization with one of the 3 outcomes of interest during the first postpartum year. Adjusted models controlled for patient age, race and ethnicity, median household income for zip code, insurance type, urban/rural residence, presence of a mental health condition or a substance use disorder during delivery, and birth outcome, as well as clustering at the patient level using cluster subcommands to account for patients with multiple deliveries during the period of analysis (n = 26,930; 15.9% of patients with deliveries between 2016 and 2018 in the sample). Analyses were conducted using Stata 15.1 software (College Station, TX).

Results

A total of 197,749 delivery hospitalizations were identified in Maryland between 2016 and 2018; 0.8% (n = 1,513) involved SMM (Fig. 1). Hemorrhage complications were the leading causes of SMM (occurring in 43.4% deliveries with SMM) and included disseminated intravascular coagulation, shock, and hysterectomy. Compared to patients without SMM, a higher proportion of patients with SMM were 35–39 years of age (21.6% vs. 17.1%, respectively) and 40 years of age or older (8.3% vs. 3.9%, respectively) (Table 1). Patients with SMM were also in higher proportion non-Hispanic Black (46.1% vs. 30.5%, respectively), with incomes in lowest income quartile for ZIP code (33.4% vs. 27.8%, respectively), and covered by public insurance (49.1% vs. 42.4%, respectively) than those without SMM. Also, a higher proportion of patients with than without SMM had a mental health condition (17.1% vs. 9.4%, respectively) or substance use disorder (6.9% vs. 3.6%, respectively) diagnosis documented during the delivery hospitalization. Additionally, the outcome of deliveries complicated by SMM were in higher proportion stillbirth in patients with SMM compared to patients without SMM (6.5% vs. 0.7%, respectively).

Fig. 1
figure 1

Flow diagram of study population

Full size image
Table 1 Characteristics of patients with and without severe maternal morbidity during delivery hospitalization
Full size table

Among patients with deliveries, 2.9% (n = 5,793) experienced hospitalization in the year following delivery. The rate of postpartum hospitalization was higher across all outcomes and time periods for patients with SMM compared to those without SMM (Fig. 2). The relative risk of early postpartum hospitalization for patients with SMM was 6.5 for any hospitalization (95% CI = 5.4–7.6), 8.8 for a hospitalization with a mental health condition diagnosis (95% CI = 5.2–14.7), 9.9 for a substance use disorder diagnosis (95% CI = 4.3, 22.6), and 13.6 for both (95% CI = 5.9–31.6) compared to patients without SMM. In the late postpartum period, the relative risk of postpartum hospitalization between patients with and without SMM for any cause was 5.2 (95% CI = 4.4, 6.1). The relative risk was 4.9 (95% CI = 3.5, 6.9), 3.6 (95% CI = 2.1, 6.2), and 4.1 (95% CI = 2.4, 7.0) for hospitalizations with a mental health condition, substance use disorder, and both, respectively. The rate of hospitalization for any reason was higher in the early postpartum than in the late postpartum period for patients with SMM (85.3 per vs. 83.2 1,000 deliveries, respectively). However, among all patients (with and without SMM) the rate of postpartum hospitalization with a mental health condition or substance use disorder was higher in the late postpartum period.

Fig. 2
figure 2

Postpartum hospitalization rates overall and among patients with a mental health condition or substance use disorder diagnoses by severe maternal morbidity status during delivery hospitalization

Note: SMM, Severe Maternal Morbidity; MH, mental health; SUD, substance use disorder. Postpartum hospitalization rate is number of hospitalizations following delivery hospitalization discharge per 1,000 deliveries.

Source: Healthcare Cost and Utilization Project (HCUP), Maryland Inpatient Database, 2016-2019. N=197,749 deliveries in 2016-2018.

Full size image

Compared with patient without SMM, those with SMM had significantly higher odds of postpartum hospitalization during the one year following delivery with a mental health condition diagnosis (OR = 5.7; 95% CI 4.2, 7.6), a substance use disorder (OR = 4.4; 95% CI 2.8, 7.1) and co-occurring mental health conditions and substance use disorder diagnoses (OR = 4.9, 95% CI 3.1, 7.9) (Table 2). Odds were attenuated by 34.2–40.2% after adjustment for the sociodemographic and delivery characteristics examined.

Table 2 Odds of postpartum hospitalization for patients with a mental health condition or substance use disorder diagnoses by severe maternal morbidity status
Full size table

Several sociodemographic and delivery characteristics were associated with the odds of postpartum hospitalization with a mental health condition or substance use disorder or both types of diagnoses. Compared to non-Hispanic White patients, patients who were Hispanic had a lower odds of postpartum hospitalization with a mental health condition (AOR = 0.5, 95% CI 0.4, 0.6), substance use disorder (AOR = 0.2, 95% CI 0.1, 0.3), or co-occurring mental health condition and substance use disorder (AOR = 0.2, 95% CI 0.1, 0.3) compared to patients who were non-Hispanic White. Though patients who were non-Hispanic Black had approximately 20% higher odds of postpartum hospitalization with a mental health condition compared to non-Hispanic White patients (in unadjusted models only), they had approximately 30% lower odds of postpartum hospitalization with a substance use disorder or co-occurring mental health condition and substance use disorder compared to non-Hispanic White patients.

By and large, the higher the patient income, the lower the odds of postpartum hospitalization with mental health condition or substance use disorder diagnoses. Compared to patients with private insurance, those with public insurance or no insurance had 1.9 times higher odds of postpartum hospitalization with a mental health condition diagnosis and over 5-times higher odds of postpartum hospitalization with substance use alone or both substance use and mental health condition diagnoses. Importantly, odds of postpartum hospitalization with a mental health condition diagnosis were significantly higher for patients with a mental health condition (AOR = 6.6; 95% CI 5.8, 7.5) or substance use disorder (AOR = 2.1; 95% CI 1.7, 2.5) diagnosis during the delivery hospitalization. Patients with a stillbirth had 2.2 times higher odds for postpartum hospitalization with a mental health condition diagnosis compared to patients with a live born infant.

Discussion

In this retrospective cohort study of deliveries in Maryland between 2016 and 2018, patients who experienced SMM during their delivery hospitalization had 3.7, 2.8 and 3 times the odds of postpartum hospitalization with a mental health condition diagnosis, substance use disorder diagnosis and both, respectively, compared to patients who did not experience SMM during delivery. Rates of postpartum hospitalization with such diagnoses were significantly higher among patients with SMM compared to those without SMM during the early and late postpartum periods. Our findings confirm prior research documenting higher rates of postpartum hospitalization among postpartum patients who experience SMM compared to those who did not experience SMM [24], and are supported by clinical plausibility with respect to the associations between SMM and presence of mental health condition and substance use disorder diagnoses. Research has shown that traumatic birth outcomes increase the risk of mental health conditions, particularly posttraumatic stress disorder, during the postpartum period [25,26,27]. Moreover, a study in Sweden found a positive association between SMM at delivery and postpartum treatment for psychiatric disorders [28]. Experience of adverse or unexpected outcomes such as preeclampsia, preterm birth, or cesarean delivery have been identified as risk factors for postpartum mental health conditions [29,30,31]. Similarly, the postpartum period is recognized as a particularly vulnerable time for individuals with substance use disorders at risk of relapse, which may be further compounded by the experience of birth trauma or adverse pregnancy outcomes [32]. Fear for personal safety or safety of the neonate and negative perceptions of birth, multiple interventions during labor and birth, and anesthesia complications are all associated with postpartum mental health conditions and can be unique vulnerabilities for those with histories of substance use disorders [32, 33]. SMM frequently includes multiple interventions as well as anesthesia and is often characterized as a traumatic event by those who experience them, which can explain the relationships we observed in our study.

Efforts to reduce preventable SMM and its effects should include recognition and management of mental health and substance use in pregnancy and postpartum, and particularly the late postpartum period. In our study, postpartum hospitalization rates for patients with mental health and substance use disorders were higher during the late postpartum period compared to the early postpartum period. Similarly, studies of pregnancy-associated mortality have identified higher rates of deaths due to overdose and suicide in the late postpartum period [34, 35]. Together, these suggest the late postpartum period is a particularly vulnerable time for these behavioral health conditions. Furthermore, our study highlights patients who experience co-occurring stillbirth and SMM as a particularly vulnerable population, as both conditions independently increase the risk for postpartum hospitalizations with mental health conditions.

Patients with SMM often receive inadequate information about their morbidity [36]. Recommendations following an SMM event include offering patients a debriefing by their clinician before hospital discharge, social support, referrals and warm hand-off to mental health and substance use providers and services, including specialized treatment [36]. Such interventions have been found to be moderately effective in reducing mental health symptoms among patients with traumatic births [37, 38]. The US Preventive Services Task Force recommends that clinicians provide or refer postpartum persons at increased risk for perinatal depression to counseling interventions due to sufficient evidence of their effectiveness [39]. Increased risk includes those with a history of depression, current depressive symptoms, socioeconomic risk factors, or a history of significant negative life events. Findings from this analysis suggest that experience of SMM should also be considered as a risk factor.

Our findings demonstrate no significant difference in the adjusted odds of postpartum hospitalization with a mental health condition between non-Hispanic Black and White patients who experience SMM, but lower odds of postpartum hospitalization for substance use disorders and both mental health conditions and substance use disorders. Additionally, odds of hospitalization with a mental health condition or substance use disorder were significantly lower among Hispanic patients and other racial/ethnic minority groups compared to White patients. More research is needed to determine whether these differences are due to true lower rates of mental health conditions and substance use disorders or differences in rates of diagnosis and recognition.

Our study has limitations. While there are indications that SMM precipitates postpartum mental health conditions and substance use, these relationships may be bidirectional, such that a history of mental health conditions or substance use predisposes pregnant individuals to SMM, which in turn exacerbates the risk of the same in the postpartum period [17]. We used the first five diagnosis codes for each patient to ascertain our outcomes of interest – this cut-off point was used to examine postpartum hospitalizations where mental health conditions and substance use disorders represented important reason(s) for the hospitalizations. However, we may have missed patients who were admitted to the hospital for these conditions but, for which, only direct pregnancy complications were noted with the first five conditions codes. We may have also missed patients who do not disclose their mental health condition or symptoms, or their substance use to a healthcare provider, or those who are less likely to be screened for such conditions including birthing people of color and those with low incomes [40]. The data are limited to conditions identified during hospitalizations, whereas many of these conditions do not result in hospitalization and may be identified in outpatient settings and treated through medication, therefore we are unable to adjust for prenatal depression and substance use, unless identified during the delivery hospitalization; moreover, only SMM during delivery hospitalization is examined, thus excluding SMM events that occur in antepartum and postpartum hospitalizations. In addition, residual confounding may be present due to the exclusion of other chronic health conditions and the limited sociodemographic variables available through hospital records. Furthermore, reliance on administrative data, which are primarily collected for billing purposes, has other limitations because all health conditions present during a hospital admission may not be consistently and accurately reported and the algorithm used to identify SMM based on this data is not well suited to identify all cases of SMM events involving hemorrhage [23].

However, the study has some important strengths. It uses a large, statewide database analyzed longitudinally over several years before the start of the COVID-19 pandemic – this was only possible given the inclusion of a unique patient identifier in the Maryland SID. The use of ICD-10 codes for outcome ascertainment has the strength of consistency in identifying cases over the study period and offers some reassurance that they represent true cases of patients with mental health conditions or substance use disorders.

Clearly establishing the directionality and causality of this relationship will require further, more robust longitudinal studies. In addition, examining the relationship of SMM with specific types of mental health conditions as well as co-occurring mental health conditions and substance use should be the focus of research when a larger sample size than ours is available.

Conclusion

Patients who experience SMM have a higher odds of hospitalization with a mental health condition or substance use disorder or both in the postpartum period. Treatment and support resources for mental health and substance use providers --including enhanced screening and personal introductions between new providers and patients when transferring care (i.e. warm handoffs) -- should be made available to patients with SMM upon discharge after delivery, and evidence-based interventions to improve mental health and reduce substance use should be prioritized in these patients.

Data availability

The data that support the findings of this study are publicly available from The Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project. HCUP State Inpatient Databases (SID). Healthcare Cost and Utilization Project (HCUP). 2015-2019. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/sidoverview.jsp.

Abbreviations

SMM:

Severe maternal morbidity

References

  1. Getahun D, Oyelese Y, Peltier M, Yeh M, Chiu VY, Takhar H, et al. Trends in Postpartum Depression by Race/Ethnicity and pre-pregnancy body Mass Index. Am J Obstet Gynecol. 2023;228(1):S122–3.

    Article  Google Scholar 

  2. Admon LK, Dalton VK, Kolenic GE, Ettner SL, Tilea A, Haffajee RL, et al. Trends in suicidality 1 year before and after birth among commercially insured Childbearing individuals in the United States, 2006–2017. JAMA Psychiatry. 2021;78(2):171–6.

    Article  PubMed  Google Scholar 

  3. McKee K, Admon LK, Winkelman TNA, Muzik M, Hall S, Dalton VK, et al. Perinatal mood and anxiety disorders, serious mental illness, and delivery-related health outcomes, United States, 2006–2015. BMC Womens Health. 2020;20(1):150.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hanson M, Hellem T, Alexander-Ruff J, Newcomer SR. Systematic review of barriers to and facilitators of screening for Postpartum Depression at Well-Child visits in the United States. Nurs Womens Health. 2024;28(3):213–21.

    Article  PubMed  Google Scholar 

  5. Rodriguez JJ, Smith VC. Epidemiology of perinatal substance use: exploring trends in maternal substance use. Semin Fetal Neonatal Med. 2019;24(2):86–9.

    Article  PubMed  Google Scholar 

  6. Haight SC, Ko JY, Tong VT, Bohm MK. WM C. pioid Use Disorder Documented at Delivery Hospitalization — United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018.

  7. Margerison CE, Roberts MH, Gemmill A, Goldman-Mellor S. Pregnancy-Associated deaths due to drugs, suicide, and Homicide in the United States, 2010–2019. Obstet Gynecol. 2022;139(2):172–80.

    PubMed  PubMed Central  Google Scholar 

  8. Trost S, Beauregard J, Chandra G, Njie F, Berry J, Harvey A et al. Pregnancy-Related Deaths: Data from Maternal Mortality Review Committees in 36 US States, 2017–2019. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2022.

  9. Howard LM, Khalifeh H. Perinatal mental health: a review of progress and challenges. World Psychiatry. 2020;19(3):313–27.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Brown CC, Adams CE, George KE, Moore JE. Mental Health conditions increase severe maternal morbidity by 50% and cost $102 million yearly in the United States. Health Aff (Millwood). 2021;40(10):1575–84.

    Article  PubMed  Google Scholar 

  11. Whiteman VE, Salemi JL, Mogos MF, Cain MA, Aliyu MH, Salihu HM. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy. 2014;2014:906723.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Leonard SA, Kennedy CJ, Carmichael SL, Lyell DJ, Main EK. An expanded Obstetric Comorbidity Scoring System for Predicting severe maternal morbidity. Obstet Gynecol. 2020;136(3):440–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Fink DA, Kilday D, Cao Z, Larson K, Smith A, Lipkin C, et al. Trends in maternal mortality and severe maternal morbidity during delivery-related hospitalizations in the United States, 2008 to 2021. JAMA Netw Open. 2023;6(6):e2317641.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Health DoR. How Does CDC Identify Severe Maternal Morbidity? 2023 [ https://www.cdc.gov/reproductivehealth/maternalinfanthealth/smm/severe-morbidity-ICD.htm

  15. Hirai AH, Owens PL, Reid LD, Vladutiu CJ, Main EK. Trends in severe maternal morbidity in the US across the Transition to ICD-10-CM/PCS from 2012–2019. JAMA Netw Open. 2022;5(7):e2222966.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lewkowitz AK, Rosenbloom JI, Keller M, Lopez JD, Macones GA, Olsen MA, et al. Association between Severe Maternal Morbidity and Psychiatric Illness within 1 year of Hospital Discharge after Delivery. Obstet Gynecol. 2019;134(4):695–707.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Attanasio L, Jeung C, Geissler KH. Association of Postpartum Mental Illness Diagnoses with severe maternal morbidity. J Womens Health (Larchmt). 2023.

  18. Elmir R, Schmied V, Jackson D, Wilkes L. Between life and death: women’s experiences of coming close to death, and surviving a severe postpartum haemorrhage and emergency hysterectomy. Midwifery. 2012;28(2):228–35.

    Article  PubMed  Google Scholar 

  19. Snowdon C, Elbourne D, Forsey M, Alfirevic Z. Information-hungry and disempowered: a qualitative study of women and their partners’ experiences of severe postpartum haemorrhage. Midwifery. 2012;28(6):791–9.

    Article  PubMed  Google Scholar 

  20. Hinton L, Locock L, Knight M. Support for mothers and their families after life-threatening illness in pregnancy and childbirth: a qualitative study in primary care. Br J Gen Pract. 2015;65(638):e563–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Conway K, Compton W, Stinson F, Grant B. DSM-IV Mood and anxiety disorders and Specific Drug Use disorders: results from the national epidemiologic survey on Alcohol and related conditions. J Clin Psychiatry. 2006;67.

  22. Manuel JI, Gandy ME, Rieker D. Trends in hospital discharges and dispositions for episodes of co-occurring severe mental illness and substance use disorders. Adm Policy Ment Health. 2015;42(2):168–75.

    Article  PubMed  Google Scholar 

  23. Main EK, Abreo A, McNulty J, Gilbert W, McNally C, Poeltler D, et al. Measuring severe maternal morbidity: validation of potential measures. Am J Obstet Gynecol. 2016;214(5):643. e1- e10.

    Article  Google Scholar 

  24. Matas JL, Mitchell LE, Sharma SV, Louis JM, Salemi JL. Severe maternal morbidity at delivery and postpartum readmission in the United States. Paediatr Perinat Epidemiol. 2021;35(6):627–34.

    Article  PubMed  Google Scholar 

  25. Di Florio A, Jones L, Forty L, Gordon-Smith K, Craddock N, Jones I. Bipolar disorder, miscarriage, and termination. Bipolar Disord. 2015;17(1):102–5.

    Article  PubMed  Google Scholar 

  26. Lewkowitz AK, Rosenbloom JI, Keller M, Lopez JD, Macones GA, Olsen MA, et al. Association between stillbirth >/=23 weeks gestation and acute psychiatric illness within 1 year of delivery. Am J Obstet Gynecol. 2019;221(5):491. e1- e22.

    Article  PubMed Central  Google Scholar 

  27. Modarres M, Afrasiabi S, Rahnama P, Montazeri A. Prevalence and risk factors of childbirth-related post-traumatic stress symptoms. BMC Pregnancy Childbirth. 2012;12.

  28. Wall-Wieler E, Carmichael SL, Urquia ML, Liu C, Hjern A. Severe maternal morbidity and postpartum mental health-related outcomes in Sweden: a population-based matched-cohort study. Arch Womens Ment Health. 2019;22(4):519–26.

    Article  PubMed  Google Scholar 

  29. Caropreso L, de Azevedo Cardoso T, Eltayebani M, Frey BN. Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Arch Womens Ment Health. 2020;23(4):493–505.

    Article  PubMed  Google Scholar 

  30. Ayers S, Bond R, Bertullies S, Wijma K. The aetiology of post-traumatic stress following childbirth: a meta-analysis and theoretical framework. Psychol Med. 2016;46(6):1121–34.

    Article  CAS  PubMed  Google Scholar 

  31. Sun L, Wang S, Li X-Q. Association between mode of delivery and postpartum depression: a systematic review and network meta-analysis. Australian New Z J Psychiatry. 2021;55.

  32. Martin CE, Parlier-Ahmad AB. Addiction treatment in the postpartum period: an opportunity for evidence-based personalized medicine. Int Rev Psychiatry. 2021;33(6):579–90.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Simpson M, Schmied V, Dickson C, Dahlen HG. Postnatal post-traumatic stress: an integrative review. Women Birth. 2018;31(5):367–79.

    Article  PubMed  Google Scholar 

  34. Han B, Compton WM, Einstein EB, Elder E, Volkow ND. Pregnancy and Postpartum Drug Overdose deaths in the US before and during the COVID-19 pandemic. JAMA Psychiatry. 2024;81(3):270–83.

    Article  PubMed  Google Scholar 

  35. Zivin K, Zhong C, Rodriguez-Putnam A, Spring E, Cai Q, Miller A, et al. Suicide mortality during the Perinatal Period. JAMA Netw Open. 2024;7(6):e2418887.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Furniss M, Conroy M, Filoche S, MacDonald EJ, Geller SE, Lawton B. Information, support, and follow-up offered to women who experienced severe maternal morbidity. Int J Gynaecol Obstet. 2018;141(3):384–8.

    Article  PubMed  Google Scholar 

  37. Baxter JD, McCourt C, Jarrett PM. What is current practice in offering debriefing services to post partum women and what are the perceptions of women in accessing these services: a critical review of the literature. Midwifery. 2014;30(2):194–219.

    Article  PubMed  Google Scholar 

  38. Gamble J, Creedy D, Moyle W, Webster J, McAllister M, Dickson P. Effectiveness of a counseling intervention after a traumatic childbirth: a randomized controlled trial. Birth. 2005;32(1):11–9.

    Article  PubMed  Google Scholar 

  39. US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Interventions to prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(6):580–7.

    Article  Google Scholar 

  40. Sidebottom A, Vacquier M, LaRusso E, Erickson D, Hardeman R. Perinatal depression screening practices in a large health system: identifying current state and assessing opportunities to provide more equitable care. Arch Womens Ment Health. 2021;24(1):133–44.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Funding for this study is from the Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD, Award Number 1R01HD112442-01. The sponsor had no role in the study design; collection, analysis, and interpretation of data; in the writing of the report; or the decision to submit the article for publication.

Author information

Authors and Affiliations

  1. Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD, USA

    Carrie L Wolfson & Andreea A Creanga

  2. Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Jessica Tsipe Angelson

  3. Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA

    Andreea A Creanga

Authors
  1. Carrie L Wolfson
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Jessica Tsipe Angelson
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Andreea A Creanga
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

All authors collectively conceived and designed the analysis. CW performed the analysis. CW and JA wrote the manuscript and AC provided critical review and feedback. All authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Carrie L Wolfson.

Ethics declarations

Ethics approval and consent to participate

The study was deemed non-human subjects research by the Institutional Review Board at the Johns Hopkins Bloomberg School of Public Health because the HCUP data are de-identified and do not contain personally identifiable information.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix

Appendix

Table A1 ICD-10-CM codes used to identify mental health conditions and substance use disorders
Full size table

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wolfson, C.L., Angelson, J.T. & Creanga, A.A. Is severe maternal morbidity a risk factor for postpartum hospitalization with mental health or substance use disorder diagnoses? Findings from a retrospective cohort study in Maryland: 2016–2019. matern health, neonatol and perinatol 11, 1 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40748-024-00198-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40748-024-00198-0

Keywords

Maternal Health, Neonatology and Perinatology

ISSN: 2054-958X

Contact us